Christopher E. G. Moore
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Physiology 12
- Nitric Oxide and Endothelin Effects 4
- Pain Mechanisms and Treatments 3
- Co-authors
- Julian Downward (10 shared papers)Sareena Rana (8 shared papers)Miriam Gómez Molina (7 shared papers)Bradley Spencer‐Dene (3 shared papers)Philip East (4 shared papers)Emma L. Nye (2 shared papers)Davide Zecchin (2 shared papers)Sophie de Carné Trécesson (3 shared papers)
- Journals
- Journal of Thrombosis and Haemostasis (3 papers)Nature Communications (3 papers)Science Translational Medicine (2 papers)European Journal of Pharmacology (2 papers)Cancer Research (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Christopher E. G. Moore
55 papers receiving 2.7k citations
Christopher E. G. Moore's Hit Papers
Peers
Comparison fields: 5 of 123
- Hepatology 188
- Oncology 624
- Immunology 497
- Molecular Biology 1.0k
- Infectious Diseases 229
Countries citing papers authored by Christopher E. G. Moore
This map shows the geographic impact of Christopher E. G. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. G. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. G. Moore more than expected).
Fields of papers citing papers by Christopher E. G. Moore
This network shows the impact of papers produced by Christopher E. G. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. G. Moore. The network helps show where Christopher E. G. Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher E. G. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA Hit paper breakdown → | 2017 | 537 |
| 2 | 2021 | 224 | |
| 3 | 2005 | 198 | |
| 4 | 2019 | 172 | |
| 5 | 2013 | 148 | |
| 6 | 2013 | 131 | |
| 7 | 2019 | 106 | |
| 8 | 2022 | 104 | |
| 9 | 2020 | 81 | |
| 10 | 2022 | 68 | |
| 11 | 2010 | 54 | |
| 12 | 2022 | 52 | |
| 13 | 2021 | 51 | |
| 14 | 2019 | 49 | |
| 15 | 2021 | 48 | |
| 16 | 1986 | 47 | |
| 17 | 2009 | 46 | |
| 18 | 2000 | 43 | |
| 19 | 2008 | 42 | |
| 20 | 2020 | 41 |
About Christopher E. G. Moore
Christopher E. G. Moore is a scholar working on Physiology, Immunology, Oncology, Cellular and Molecular Neuroscience and Molecular Biology, having authored 57 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Nitric Oxide and Endothelin Effects (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Ion channel regulation and function (3 papers), Platelet Disorders and Treatments (3 papers), Motor Control and Adaptation (3 papers) and Pain Mechanisms and Treatments (3 papers). The work is most often cited by research in Hepatology (188 citations), Oncology (624 citations), Immunology (497 citations), Molecular Biology (1.0k citations) and Infectious Diseases (229 citations). Christopher E. G. Moore has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Julian Downward, Sareena Rana, Miriam Gómez Molina, Bradley Spencer‐Dene, Philip East, Emma L. Nye, Davide Zecchin, Sophie de Carné Trécesson, Wi S. Lai and Perry J. Blackshear. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Nature Communications, Science Translational Medicine, European Journal of Pharmacology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.